Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01616082 · ClinicalTrials.gov registry record · NA
Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)
A NA study, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT01616082 is a NA study that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 39 participants.
The verdict
NCT01616082, a NA study, has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the different ways our bodies burn fat which may be important for obesity, diabetes, and cardiovascular disease.
Interventions
- DRUG Phentermine
- BEHAVIORAL Low Calorie Diet (LCD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01616082
The ClinicalTrials.gov registry entry for NCT01616082 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phentermine is the first listed.
NCT01616082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01616082 about?
NCT01616082 is a clinical study titled "Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)". The purpose of this study is to better understand the different ways our bodies burn fat which may be important for obesity, diabetes, and cardiovascular disease.
What is the current status of trial NCT01616082?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2011-09. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01616082?
The interventions under investigation include: Phentermine (DRUG), Low Calorie Diet (LCD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01616082?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.